What is survodutide?
Survodutide is a new weekly injection being studied to help people lose weight and improve their metabolism. It targets 2 natural hormones linked to hunger and how the body uses energy. Survodutide is still in clinical trials and is not available to buy in the UK or anywhere else.
Survodutide has been developed by Boehringer Ingelheim and Zealand Pharma. It’s known as a dual-action medication because it activates both GLP-1 and glucagon receptors. These hormones help control appetite, blood sugar, and the way the body breaks down fat.
Other medications like liraglutide and Wegovy act only on the GLP-1 receptor, but because survodutide also activates the glucagon receptor, it may boost fat burning.
At the moment, survodutide is only being tested in research settings. It has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK or by any other regulator. This means people can only receive it as part of a clinical study until testing is complete.
How effective is survodutide?
Survodutide has shown strong early effects for weight loss and overall health. People lost a large amount of weight, had less body fat, and showed better signs of metabolic health.
Key findings from current research include:
- weight loss of around 15 to 19% in many patients
- less body fat and smaller waist sizes
- improvements in liver health for many people with MASH
- better control of blood sugar
Scientists now need more long-term studies to confirm these benefits and to compare Survodutide directly with newer treatments like Wegovy, Mounjaro and Ozempic.
| Survodutide | 5mg*10vials, 10mg*10vials |
|---|
Related products
GLP3-Retatrutide
Price range: $60.00 through $430.00FOXO4 10mg
$300.00Cagrilintide
Price range: $100.00 through $150.00GHK-CU
Price range: $35.00 through $60.00
Reviews
There are no reviews yet.